Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
Program: State-of-the-Art Interdisciplinary Management of Prostate Cancer This series is part of an Independent Medical Education Initiative Supported by BAYER U.S. LLC PHARMACEUTICALS Biographies: Rana…
Novo Nordisk on Thursday defended the prices of its blockbuster diabetes and obesity drugs Ozempic and Wegovy amid a Senate probe into what the company…
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
Join us to hear from innovative investors and entrepreneurs offering novel approaches to solve some of healthcare’s greatest challenges.
Mariana Oncology brings Novartis a lead radiopharmaceutical program in development for small cell lung cancer. The deal is the latest in a string of big…
This report describes emergency department visits for traffic-related pedestrian injuries.
Over the last decade, private equity firms acquired scores of wheelchair makers. Now, users routinely wait months to get their chairs repaired.
Aaron Laviana discusses a study on reducing opioid use after robotic urologic surgery in a safety-net hospital. The study introduces a simplified opioid minimization protocol,…
Animal healthcare company Zoetis surpassed analysts’ expectations for first-quarter profit on Thursday, helped by strong demand for its medicines and vaccines for pets.
Nature Communications – There are limited treatment options for infection with Crimean-Congo hemorrhagic fever virus in humans. Here, the authors show that a monoclonal antibody…